Elsevier

Experimental Gerontology

Volume 86, 15 December 2016, Pages 97-105
Experimental Gerontology

Aging and adipose tissue: potential interventions for diabetes and regenerative medicine

https://doi.org/10.1016/j.exger.2016.02.013Get rights and content
Under a Creative Commons license
open access

Highlights

  • Adipose tissue is a highly relevant organ for the study of aging.

  • Age-related changes occur in adipose tissue.

  • Adipose tissue function impacts lifespan and healthspan.

  • Obesity and aging have shared mechanisms and effects on adipose tissue.

  • Improved knowledge of adipose tissue aging could impact diabetes treatments and regenerative medicine.

Abstract

Adipose tissue dysfunction occurs with aging and has systemic effects, including peripheral insulin resistance, ectopic lipid deposition, and inflammation. Fundamental aging mechanisms, including cellular senescence and progenitor cell dysfunction, occur in adipose tissue with aging and may serve as potential therapeutic targets in age-related disease. In this review, we examine the role of adipose tissue in healthy individuals and explore how aging leads to adipose tissue dysfunction, redistribution, and changes in gene regulation. Adipose tissue plays a central role in longevity, and interventions restricted to adipose tissue may impact lifespan. Conversely, obesity may represent a state of accelerated aging. We discuss the potential therapeutic potential of targeting basic aging mechanisms, including cellular senescence, in adipose tissue, using type II diabetes and regenerative medicine as examples. We make the case that aging should not be neglected in the study of adipose-derived stem cells for regenerative medicine strategies, as elderly patients make up a large portion of individuals in need of such therapies.

Keywords

Aging
Adipose Tissue
Insulin Resistance
Preadipocyte
Stem Cell
Cellular Senescence

Cited by (0)